A risk group indicates the possibility that the disease may be associated with the risk of vital substance deficiency (micronutrients). The complaint glaucoma indicates a vital substance (micronutrient) deficiency for:
- Vitamin B1
- VItamin B6
- Vitamin B12
- Folic acid
Within the framework of micronutrient medicine (vital substances), the following vital substances (micronutrients) are used for supportive therapy:
- Vitamin A
- Vitamin C
- Vitamin E
- Vitamin B1
- Vitamin B2
- Vitamin B3
- Vitamin B6
- VItamin B12
- Magnesium
- Alpha lipoic acid
- Cytidine-5′-monophosphoric acid (CMP)
- Cytidine-5′-diphosphocholine (citicoline)
- Eicosapentaenoic acid (EPA)
- Docosahexaenoic acid (DHA)
The above vital substance recommendations (micronutrients) were created with the help of medical experts. All statements are supported by scientific publications with high levels of evidence. For a therapy recommendation, only clinical studies with the highest degrees of evidence (grade 1a/1b and 2a/2b) were used, which due to their high significance prove the therapy recommendation. These data are updated at certain intervals.
* Vital nutrients (macro- and micronutrients) include vitamins, minerals, trace elements, essential amino acids, essential fatty acids, etc.
